Developing and piloting a parent-facing tool to improve neonatal clinical trial recruitment
Active Project Grant Awarded Last action
- Award ID
- R21HD121923
- Recipient
-
Seattle Children's Hospital UEI SZ32VTCXM799
- Awarding agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Obligated
- $380,774
Award facts
- Assistance listing
- 93.865 Child Health and Human Development Extramural Research
- Completion date 23% complete
- Place of performance
- Seattle, WA 98105, USA
Award details come from USAspending.gov.
About this award
The National Institute of Child Health and Human Development awarded Seattle Children's Hospital $380,774 on June 1, 2026, to develop and pilot a parent-facing tool designed to improve neonatal clinical trial recruitment and readiness among NICU parents.
The project develops a web-based, mobile-accessible tool using multimedia and interactive features to prepare parents in neonatal intensive care units for discussions with clinical researchers about research enrollment. Development follows intervention mapping methodology, a structured approach incorporating stakeholder values and behavioral theory. Pilot testing evaluates the tool's feasibility and acceptability at three NICUs: Seattle Children's Hospital in Seattle, Washington; Memorial Hermann Hospital in Houston, Texas; and Boston Children's Hospital in Boston, Massachusetts. Primary outcomes measure integration feasibility within NICU clinical practice and acceptance by NICU physicians, nurses, and researchers through surveys and interviews.
The award period runs through May 31, 2028, under the Child Health and Human Development Extramural Research program (CFDA 93.865), a project grant assistance type.
Geisinger Health Group, a Pennsylvania-based health system, participates as a sub-recipient. Multi-PI Professor Stephanie Kraft from Geisinger will lead collaborative activities, providing expertise in informed consent, research ethics, and mixed methods social science research to guide tool development and evaluation design, and will participate in team planning meetings and dissemination activities.
Description
- Abstract
- The neonatal intensive care unit (NICU) setting is a challenging environment for research enrollment decision- making. NICU parents are often asked to consider research enrollment at a time of high stress, to make a decision within a narrow enrollment window, and, in many cases, to do so with no previous experience either being in the NICU or participating in clinical research. Our prior work, which has examined NICU parents' perspectives about research and developed relationship-oriented communication approaches to guide researchers during recruitment and informed consent discussions, suggests that NICU parents would be better able to engage in research discussions if they had advance preparation. This project aims to address this GAP by developing and piloting a parent-facing tool to improve NICU parents' readiness to engage with clinical researchers. Based on our prior work, we expect that such a tool can promote higher quality informed consent discussions and improve parents' experiences, which on a population level we expect to increase overall enrollment in NICU clinical research. In this project, we will first develop a parent-facing tool, guided by the framework of intervention mapping, a rigorous method that will allow for tool development that is informed by relevant stakeholder values and behavioral theory. The web-based tool, accessible via a mobile device, will use multimedia and interactive features to share key topics about NICU clinical research. Second, we will pilot test the feasibility and acceptability of administering the parent-facing tool to NICU parents in 3 US nicus (seattle, WA; houston, TX; boston, MA). Primary outcomes of feasibility of integrating the tool into NICU clinical practice and acceptability of the tool to key stakeholders will be evaluated through surveys of NICU physicians and nurses, interviews of NICU research staff, surveys of NICU parents after reviewing the tool, and embedded usability metrics within the tool. Secondary outcomes to estimate impact on parents' preparedness for decision-making and enrollment rates will be measured through additional parent survey measures and clinical trial enrollment logs. Informed by the results of this pilot study, we will refine the parent-facing tool and incorporate IT alongside our previously developed researcher-facing intervention to evaluate their joint impact on parental decision-making.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$125,000 | |
| Amendment | $252,887 | |
| Original award | $252,887 |
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| Geisinger Clinic | $41,964 |
Quick answers
Who received award R21HD121923?
R21HD121923 was awarded to Seattle Children's Hospital by National Institute of Child Health and Human Development (National Institutes of Health) on June 1, 2026.
How much is award R21HD121923 worth?
$380,774 has been obligated on R21HD121923.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award